No abstract available
MeSH terms
-
Antiviral Agents / administration & dosage*
-
Antiviral Agents / pharmacokinetics
-
Carcinoma, Hepatocellular / etiology
-
Carcinoma, Hepatocellular / prevention & control
-
Drug Therapy, Combination
-
Genotype
-
Hepacivirus / genetics
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / virology
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage*
-
Interferon-alpha / pharmacokinetics
-
Liver Cirrhosis / etiology
-
Liver Cirrhosis / prevention & control
-
Liver Neoplasms / etiology
-
Liver Neoplasms / prevention & control
-
Polyethylene Glycols / administration & dosage*
-
Polyethylene Glycols / pharmacokinetics
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Ribavirin / administration & dosage
-
Time Factors
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2b
-
peginterferon alfa-2a